杨志云（主任医师）就职于首都医科大学附属北京地坛医院中西医结合二科，擅长中西医结合各种慢性肝病、肝硬化及各种并发症、慢性乙型肝炎等。本页整理其个人简介、擅长领域与就诊信息，并附同院同科室医生，供就诊参考。
杨志云，首都医科大学附属北京地坛医院中西医结合中心主任医师，教授，博导，科教处处长。北京市卫生系统高层次人才，第六批全国老中医药专家学术经验继承人 。
从事中西医结合肝病诊疗与研究20余年，在中西医结合治疗肝癌、肝硬化及并发症、病毒性肝炎、脂肪性肝病等方面有丰富经验。
主要研究方向
中西医结合治疗肝癌、肝硬化及并发症、病毒性肝炎、脂肪性肝病等方面有丰富经验。
社会任职
- 北京中西医结合肝病学会秘书长
- 中国医师协会中西医结合肝病学会常委
获奖荣誉
- 省部级以上奖项3项
科研成果
- 近5年承担国家及北京市自然基金3项。
- 发表SCI论文18篇。
- 授权发明专利1项。
- 发表代表论文及著作：
- 1.Zhiyun Yang, Li Wang, Yixin Hou, Xianbo Wang. Effects of matrine on oval cell-mediated liver regeneration and expression of RBP-Jκ and HES1[J]. Molecular Medicine Reports, 2013, 7(5): 1533-1538
- 2.Lingling He, Xiaoli Liu, Lijia Wang, Zhiyun Yang. Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials[J]. Medicine, 2016, 95(42): e4947
- 3.Xiaoli Liu, Lingling He, Junyan Han, Lijia Wang, Mengge Li, Yuyong Jiang, Xianbo Wang, Zhiyun Yang. Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer[J]. PLoS One, 2017, 12(2): e0170605
- 4. Lingling He, Shuan Zhang, Xiaoli Liu, Yuyong Jiang, Xianbo Wang, Zhiyun Yang. HbA1c-based score model for predicting death risk in patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus[J]. Journal of Diabetes Research, 2017, 2017: 3819502
- 5.Lingling He, Xiaoli Liu, Yalin Zhao, Shuan Zhang, Yuyong Jiang, Xianbo Wang, Zhiyun Yang. Efficacy of nucleot(s)ide analogs therapy in patients with unresectable HBV-related hepatocellular carcinoma: a systematic review and meta-analysis[J]. Disease Markers, 2017,ID 7075935
- 6.Shuan Zhang, Lingling He, Xinhui Wang, Zhibo Dang, Xiaoli Liu, Mengge Li, Xianbo Wang, Zhiyun Yang, A Novel Scoring model for predicting mortality risk in patients with cirrhosis and hepatorenal syndrome[J]. European Journal of Gastroenterology and Hepatology, 2018, 30(8): 938-943.
- 7.Xiaoli Liu, Mengge Li, Xinhui Wang, Zhibo Dang, Yuyong Jiang, Xianbo Wang, Zhiyun Yang. Effect of serum triglyceride level on the prognosis of patients with hepatocellular carcinoma in the absence of cirrhosis[J]. Lipids in health and disease, 2018, 17(1): 248.
- 8.Zhibo Dang, Xiaoli Liu, Mengge Li,Xinhui Wang, Yuyong Jiang, Xianbo Wang, Zhiyun Yang, Comparative effectiveness and safety of traditional Chinese medicine supporting Qi and enriching blood for cancer related anemia in patients not receiving chemoradiotherapy: a meta-analysis and systematic review [J]. Drug Design, Development and Therapy, 2019, 13: 221.
- 9.Lingling He, Xiaoli Liu, Shuan Zhang, Mengge Li, Xianbo Wang, Yuyong Jiang, Zhiyun Yang, Independent risk factors for postoperative 1-year recurrence in patients with HBV-related hepatocellular carcinoma ≤3 cm, Gastroenterology Report, accepted.
- 10.Xinhui Wang, Xiaoli Liu, Zhibo Dang, Lihua Yu, Yuyong Jiang, Xianbo Wang, Zhiyun Yang*, Nucleos(t)ide analogues for reducing hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta-analysis, Gut and Liver, accepted.
- 11.Xiaoli Liu, Mengge Li, Xinhui Wang, Zhibo Dang, Lihua Yu, Xianbo Wang, Yuyong Jiang, Zhiyun Yang*, Effects of Adjuvant Traditional Chinese Medicine Therapy on Long-term Survival in Patients with Hepatocellular Carcinoma, Phytomedicine，accepted.
- 承担科研项目情况
- 1.国家自然科学基金项目《苦参碱与肝卵圆细胞移植协同治疗急性肝衰竭的实验研究》（编号：30873423）。
- 2.国家自然科学基金项目《养阴扶正解毒方逆转T细胞功能耗竭治疗乙肝相关原发性肝癌的机制研究》（编号：81874435）。
- 3.北京市自然科学基金项目《WNT信号通路在慢性乙型肝炎肝纤维化进程中作用及凉血解毒方干预机制研究》（编号：7142081）。
- 4.北京市科学技术委员会“首都临床特色应用研究”重点项目《基于综合预警模型筛选养阴扶正解毒法降低小肝癌微创术后复发率的优势人群临床研究》（编号：Z171100001017082）。
- 获得专利及成果
- 专利名称:用CD8阳性的 T 细胞上 PD-1 和 TIGIT 确定 HBV 相关原发性肝癌预后的系统
- 专利号：201711436077.3
